Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
Canada
Stollery Children's Hospital, Edmonton, Alberta Childrens and Womens Health Centre of British Columbia - British Columbia Childrens Hospital, Vancouver, British Columbia Children's Hospital, London Health Sciences Centre, London, Ontario The Hospital for Sick Children, Toronto, Ontario CHU Sainte-Justine, Montreal, Quebec